Quality of life and costs of spasticity treatment in German stroke patients.

Health Econ Rev · 2016 · PMC4938805 · PMID 27393633

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

The results were highly significant for all group comparisons between incobotulinumtoxinA treatment and conventional antispastic treatment (Fisher ́s exact test, p < 0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.